Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 15 |
|
|||||
| News | (2) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 399.92 | 06:19:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 399.92 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 6 | 15 | - | 316.43 - 448.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:56:03 | 3 | $ 399.92 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 103.3B | 258.31M | - | 9.92B | 3.57B | 13.82 | 28.93 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 396.88 | 406.34 | 391.01 | 395.42 | 1,045,903 | 3.04 | 0.77% |
| 1 Month | 417.38 | 421.45 | 391.01 | 403.52 | 965,916 | -17.46 | -4.18% |
| 3 Months | 430.00 | 448.40 | 391.01 | 417.33 | 1,217,888 | -30.08 | -7.00% |
| 6 Months | 363.25 | 448.40 | 341.90 | 400.75 | 1,332,423 | 36.67 | 10.09% |
| 1 Year | 331.06 | 448.40 | 316.43 | 376.03 | 1,239,041 | 68.86 | 20.80% |
| 3 Years | 217.07 | 448.40 | 176.36 | 280.69 | 1,513,974 | 182.85 | 84.24% |
| 5 Years | 169.22 | 448.40 | 164.07 | 257.98 | 1,542,771 | 230.70 | 136.33% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
